Ubs Group Ag Alvotech Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
A detailed history of Ubs Group Ag transactions in Alvotech stock. As of the latest transaction made, Ubs Group Ag holds 42,603 shares of ALVO stock, worth $368,089. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,603
Previous 47,583
10.47%
Holding current value
$368,089
Previous $460,000
15.65%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ALVO
# of Institutions
52Shares Held
16.4MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.23MShares$36.6 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$23.4 Million14.1% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.56MShares$13.5 Million0.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.39MShares$12 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$11.4 Million11.48% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.15B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...